TED W LOVE Insider Trading
Get free email notifications about insider trading for TED W LOVE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TED W LOVE. TED W LOVE is a President and C.E.O. in ARCA biopharma, Inc. ($ABIO) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in AMICUS THERAPEUTICS INC ($FOLD) and a Director in PORTOLA PHARMACEUTICALS INC ($PTLA) and a Director in KALOBIOS PHARMACEUTICALS INC ($KBIO) and a Director in Oncothyreon Inc. ($ONTY) and a CEO and President in Global Blood Therapeutics, Inc. ($GBT) and a President and CEO in Global Blood Therapeutics, Inc. ($GBT) and a See Remarks in Global Blood Therapeutics, Inc. ($GBT) and a See Remarks. in Global Blood Therapeutics, Inc. ($GBT) and a Director in Royalty Pharma plc ($RPRX).
Address: NUVELO, INC. 675 ALMANOR AVENUE SUNNYVALE 94085 CA
Companies in which TED W LOVE is an Insider
AMICUS THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TED W LOVE: Director
Holdings: 131,000 shares
Current Value: $788,620
Latest Transaction: Jun 08 2020
$FOLD Market Capitalization: $869.61M
$FOLD Previous Close: $6.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARCA biopharma, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of TED W LOVE: President and C.E.O.
Holdings: 2,378 shares
Current Value: $6,183
Latest Transaction: Aug 03 2005
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of TED W LOVE: Director
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Global Blood Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TED W LOVE: President and CEO, See Remarks., CEO and President, See Remarks
Holdings: 791,834 shares
Current Value: $12,827,711
Latest Transaction: Feb 03 2021
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HUMANIGEN, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TED W LOVE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 14 2015
$KBIO Market Capitalization: $44.71M
$KBIO Previous Close: $2.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PORTOLA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TED W LOVE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 02 2020
$PTLA Market Capitalization: $1.55B
$PTLA Previous Close: $28.28
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Royalty Pharma plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of TED W LOVE: Director
Holdings: 22,866 shares
Latest Transaction: Jun 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of TED W LOVE: Director
Holdings: 1,799 shares
Current Value: $109,361
Latest Transaction: Aug 18 2020
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of TED W LOVE
Sentiment: All, FOLD, ABIO, CASC, GBT, KBIO, PTLA, RPRX, SGEN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2021 | RPRX | Royalty Pharma plc | LOVE TED W | Director | Grant | A | 0.00 | 5,726 | 0 | 22,866 | 17.1 K to 22.9 K (+33.41 %) |
| Jun 29 2021 | RPRX | Royalty Pharma plc | LOVE TED W | Director | Grant | A | 0.00 | 5,726 | 0 | 22,866 | 17.1 K to 22.9 K (+33.41 %) |
| Feb 03 2021 | GBT | Global Blood Thera ... | LOVE TED W | President and CEO | Option Exercise | M | 0.00 | 8,955 | 0 | 53,730 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | LOVE TED W | President and CEO | Option Exercise | M | 0.00 | 11,250 | 0 | 45,000 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | LOVE TED W | President and CEO | Option Exercise | M | 0.00 | 9,750 | 0 | 19,500 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | LOVE TED W | President and CEO | Option Exercise | M | 0.00 | 12,063 | 0 | 0 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | LOVE TED W | President and CEO | Payment of Exercise | F | 49.49 | 17,893 | 885,525 | 773,941 | 791.8 K to 773.9 K (-2.26 %) |